05

2018-05

2018

The Traditional Chinese Medicine Preparations Full Industry Chain Technology Research and Development and Industrialization Project won our province's "Five 100" Excellent Projects.

View Details

08

2017-08

Dr. Wu Feichi, Chairman of Zhengqing Group: To help Nanyang Wenhe Orthopedic Hospital build a national model research and teaching base!

Recently, Dr. Wu Feichi, Chairman of Hunan Zhengqing Group, and his delegation braved the scorching heat to visit the scientific research and teaching base of Nanyang Wenhe Orthopedic Hospital in Henan for inspection and guidance. Dean Wu Taian of Nanyang Wenhe Orthopedic Hospital, Manager Li Xinguo of Nanyang Puqiang Pharmaceutical Co., Ltd., the Nanyang general distributor, and relevant leaders and experts participated in the reception.

View Details

06

2017-06

[Hunan Satellite TV News Broadcast] Bater came to Hunan for investigation to innovate reproducible and scalable poverty alleviation models.

From May 17th to 19th, Bater, Deputy Head of the United Front Work Department of the CPC Central Committee, Director of the National Ethnic Affairs Commission, and Secretary of its Party Leadership Group, led a delegation to Hunan to conduct research on ethnic affairs and regional development and poverty alleviation work in the Wuling Mountain area. During the visit, Du Jiahao, Secretary of the Provincial Party Committee and Director of the Standing Committee of the Provincial People's Congress, held discussions with Bater and his delegation.

View Details

06

2017-06

[Industry Interview] Zhengqing Pharmaceutical Chairman Wu Feichi: Aggregating Resources to Build a National Brand in the Rheumatism and Pain Market

[Menet.com] Building a brand is a reflection of a country's economic capability, an industry's creative ability, and even an entrepreneur's vision and pursuit. In the pharmaceutical industry, shaping products into national brands holds even greater significance, as we have trodden the path of 'wild' growth and imitation for too many years. When we finished interviewing Wu Feichi, Chairman of Zhengqing Pharmaceutical Group, we found that this elegant, rigorous entrepreneur, who started as a pharmaceutical engineer, has a special affection for the Zhengqing Fengtongning series products. This affection concerns the entrepreneur's values, the company's future, and even more so, the rise of national brands in the rheumatism and pain medication market.

View Details

11

2015-11

[China Traditional Chinese Medicine News] Public Hospitals Returning to Public Welfare Is Not the Panacea for Medical Reform—A Discussion with Academician Zhong Nanshan

During this year's Two Sessions, Zhong Nanshan, a national people's congress representative and academician of the Chinese Academy of Engineering, proposed that "public hospitals should return to their public welfare nature; this is the crux of medical reform." Mr. Zhong Nanshan is my teacher, and I respect him very much. Aristotle once said, "I love my teacher, but I love the truth even more." As someone who has worked in the pharmaceutical industry for over 20 years, I disagree with Mr. Zhong Nanshan's view on medical reform.

View Details

09

2014-09

Notice from Hunan Zhengqing Pharmaceutical Group Co., Ltd. regarding the 2013 Annual Shareholders' Meeting

View Details

08

2014-08

Zhengqing Pharmaceutical Group's equity confirmation work is nearing its end.

View Details

07

2014-07

Waiting shines brightly because of hope

Our reporter (Correspondent Yang Lijun) "Zhengqing is indeed a responsible enterprise. After nearly 20 years, they are still confirming equity, which not only gives us hope but also makes us trust this company more." "We've held the shares for nearly 20 years, and their intrinsic value is no longer important to us. What excites us about this equity confirmation is not the monetary value, but Zhengqing Group's sense of responsibility towards its shareholders." ...At the equity confirmation sites in Changsha and Hengyang, many shareholders excitedly shared and exchanged their thoughts.

View Details

06

2014-06

Notice of the First Extraordinary General Meeting of Shareholders 2010

Dear Shareholders and Shareholder Proxies: According to the resolution of the 10th meeting of the 3rd Board of Directors of Hunan Zhengqing Pharmaceutical Group Co., Ltd. on September 26, 2009, it was decided to convene the First Extraordinary General Meeting of Shareholders for the year 2010. The relevant matters are hereby notified as follows: I. Matters to be reviewed at this Extraordinary General Meeting of Shareholders: (I) Review the report from the company's Board of Directors, "Regarding the Reorganization and Development Plan of Zhengqing Group," and submit it to the General Meeting of Shareholders for voting and approval. (II) Review the company's proposal, "Regarding the Introduction of Strategic Investors, Disposal of Zhengqing Group's Debt to Agricultural Bank, and Reorganization of Zhengqing Group," and submit it to the General Meeting of Shareholders for voting and approval. (III) Review the proposal, "Regarding the Prompt Resumption of Intravenous Drip Product Houttuynia Cordata Injection," and submit it to the General Meeting of Shareholders for voting and approval. (IV) Review the proposal, "Regarding Cooperating with Huaihua Municipal Government to Actively Operate 'Xiangxi Traditional Chinese Medicine Valley' and 'Traditional Chinese Medicinal Materials Logistics Center'," and submit it to the General Meeting of Shareholders for voting and approval. (V) Review the proposal, "Regarding Reducing Shares Held in Huaihua Zhenghao Pharmaceutical Co., Ltd.," and submit it to the General Meeting of Shareholders for voting and approval. (VI) Review the proposal, "Regarding Converting Debt of China Hi-Tech Investment Group Corporation into Equity," and submit it to the General Meeting of Shareholders for voting and approval. For this General Meeting of Shareholders, the company will entrust lawyers to attend and issue legal opinions. II. Attendees of the Meeting: (I) All shareholders or shareholder proxies registered as of January 31, 2010 (the shareholder proxy does not necessarily have to be a company shareholder). (II) Company Directors, Supervisors, Board Secretaries, and other Senior Management personnel. (III) Lawyers appointed by the company and other personnel invited by the company's Board of Directors. III. Method of Attending the Meeting: (I) State-owned share shareholders shall register with a copy of the legal entity registration certificate from the state-owned asset management department or state-authorized shareholding unit (with official seal), and legal entity share shareholders shall register with a copy of their enterprise legal entity business license (with official seal), shareholder account card, and legal representative certificate. For attendance by proxy, the proxy must also present the legal representative's power of attorney and the proxy's own identity card for registration. (II) Internal employee share shareholders shall register with their own identity card and shareholder account card. For attendance by proxy, the proxy must also present the principal's power of attorney and the proxy's own identity card for registration. (III) Registration Location: Company Auditorium (Zhengqing Group, No. 288 Zhengqing Road, Huaihua City). (IV) Registration Time: February 5-6, 2010 (No registration will be processed after this period). IV. Meeting Time: 9:30 AM on February 7, 2010 (Saturday), for half a day. V. Meeting Location: Company Auditorium (Zhengqing Group, No. 288 Zhengqing Road, Huaihua City). VI. Other Matters: (I) Attendees' travel and accommodation expenses are self-borne. (II) Company Contacts: Zhang Guodong, Xiang Weiguo, Zhou Tingyan. (III) Company Contact Numbers: Huaihua 0745-2352540 (Yang Xiuchun, Peng Meitao, Li Jie) Changsha 0731-85226340 ext. (Qiu Qunying, Fu Rong) (IV) Company Contact Address: No. 288 Zhengqing Road, Huaihua City; Postal Code: 418000. 0745-2352068 (Huaihua Fax) 0731-85216892 (Changsha Fax) Board of Directors of Hunan Zhengqing Pharmaceutical Group Co., Ltd. January 20, 2010 Attachment: Power of Attorney Power of Attorney I hereby fully authorize Mr./Ms. _______ to represent me/my company at the First Extraordinary General Meeting of Shareholders for the year 2010 of Hunan Zhengqing Pharmaceutical Group Co., Ltd., and to exercise voting rights on my/our behalf. Principal: _______ Proxy: _______ Principal's Securities Account No.: _______ Proxy's ID Card No.: _______ Date of Authorization: _______ Number of Shares Held by Principal: _______ Signature of Principal: _______ Year Month Day

View Details